Who should we trust on science diplomacy and COVID-19 recovery? Not Big Tobacco

Alice Fabbri, Louis Laurence, Mateusz Zatoński, Anna B Gilmore On April 20th the magazine Foreign Policy will hold a Virtual Dialogue on “Science Diplomacy”. The event will focus on “elevating the role of science in addressing global challenges” including recovery from the COVID-19 pandemic. One of the event’s aims is to “energize international cooperation on […]

Read More…

Perils of the tipping point of Big Tobacco 2.0 taking over the legal cannabis industry

Andy SL Tan and Shaleen Title Big Tobacco is increasingly poised to become a significant player in the new legal cannabis industry and potentially crowd out smaller businesses. In January 2016, Philip Morris International invested $20 million in Israel-based Syqe Medical that developed a medical cannabis inhaler. In June 2018, Britain’s Imperial Brands invested through […]

Read More…

Australia: Big Tobacco wins in defeat of T21 age bill

  Kathryn Barnsley An innovative legislative reform in Tasmania, Australia has been defeated, after what appears to be tobacco industry interference via third parties, with support from vaping lobby groups. A 2018 bill to gradually phase in and raise the minimum legal sales age of e-cigarettes and tobacco to 21 years (T21) now law in […]

Read More…

Malaysia: did the tobacco industry collaborate with media to defeat tax increase?

Mohamad Haniki Nik Mohamed It has been five years since Malaysia last had a tobacco tax increase. The 2021 budget, announced in November 2020, was an opportunity to correct this shortcoming and use one of the most cost-effective measures available to governments to reduce smoking. Instead, tobacco taxes remained static for the sixth year. The […]

Read More…

Monitoring and Exposing Tobacco Industry Interference in U.S. Public Policy

Nichelle Gray, Kathleen Hoke and Doug Matheny As the United States and the world grapples with the COVID-19 pandemic, it is important to recognize underlying issues that still drastically impair public health. Tobacco use remains the leading cause of disease and early death in the U.S., accounting for 480,000 deaths annually, including 41,000 from secondhand […]

Read More…

Spain: Civil Rights and Public Health Organizations Press Government for a Tobacco Endgame by 2030

Laurent Huber, Ubaldo Cuadrado García de Arboleya, Raquel Fernández Megina and Leonardo Visconti More than twenty civil rights associations and public health organizations in Spain have backed a Declaration asking the Spanish Government for a Tobacco Endgame by 2030. The goal is ambitious: to decrease smoking prevalence in Spain to under 5% by 2030. The […]

Read More…

Tobacco industry lobbies Bangladesh Government Agency to champion its business during COVID-19 pandemic

ABM Zubair Bangladesh has seen an unprecedented level of tobacco industry interference during the COVID-19 crisis. The tobacco industry in Bangladesh, dominated by two transnational tobacco companies, British American Tobacco Bangladesh (BATB) and Japan Tobacco International (JTI), has exploited the ongoing pandemic to protect its cigarette business. While publicly building their image by making donations […]

Read More…

China’s e-cigarette manufacturers facing uncertain future

  Ross MacKenzie, Jennifer Fang and Julia Smith China’s electronic cigarette (e-cigarette) industry accounts for close to 90% of global production. Based in Shenzhen in Guangdong province, an estimated 3,900 manufacturers employed some 2 million people in 2018 and reported sales of 33.7bn yuan (US$ 4.8bn) and exports worth 28.7bn yuan (US$ 4bn). Figures for […]

Read More…

The two faces of the tobacco industry during the COVID-19 pandemic

Mateusz Zatoński, Anna B. Gilmore, Thomas R. Hird Since COVID-19 was declared a pandemic by the World Health Organization (WHO) on 11 March 2020, the world’s major tobacco companies have geared their CSR efforts to present themselves as allies of public health in the fight against the virus. For example, in Georgia on 23-26 March […]

Read More…

Article 5.3 of the WHO Framework Convention on Tobacco Control & the COVID19 Pandemic

Stella Aguinaga Bialous & Becky Freeman Article 5.3 implementation guidelines of the WHO Framework Convention on Tobacco Control (FCTC) remind all parties to protect public health against the “commercial or other vested interests” of the tobacco industry.  The guidelines recognize a “fundamental and irreconcilable” conflict of interest between tobacco industry ambitions and public health policy […]

Read More…